The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening

Comparing the performance of six human papillomavirus tests in a screening population

(2013) J Cuzick et al.   BRITISH JOURNAL OF CANCER

Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities

(2013) David Mesher et al.   EUROPEAN JOURNAL OF CANCER

Primary Cervical Cancer Screening and Triage Using an mRNA Human Papillomavirus Assay and Visual Inspection

(2013) Lucybeth Nieves et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening

(2013) A. T. Hesselink et al.   JOURNAL OF CLINICAL MICROBIOLOGY

APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results

(2012) Mark H. Stoler et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (The FASE Study)

(2012) Joseph Monsonego et al.   GYNECOLOGIC ONCOLOGY

The APTIMA HPV assayversusthe hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: A meta-analysis of the diagnostic accuracy

(2012) Marc Arbyn et al.   INTERNATIONAL JOURNAL OF CANCER

Comparison of Seven Tests for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears: the Predictors 2 Study

(2012) Anne Szarewski et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: Results from a multicenter study

(2012) Francesco Broccolo et al.   JOURNAL OF MEDICAL VIROLOGY

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study

(2010) Joseph Monsonego et al.   INTERNATIONAL JOURNAL OF CANCER

Performance of the Aptima High-Risk Human Papillomavirus mRNA Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology

(2010) A. Clad et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Aptima HPV E6/E7 mRNA Test Is as Sensitive as Hybrid Capture 2 Assay but More Specific at Detecting Cervical Precancer and Cancer

(2010) S. Ratnam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison of the Clinical Performance of PapilloCheck Human Papillomavirus Detection with That of the GP5+/6+-PCR-Enzyme Immunoassay in Population-Based Cervical Screening

(2009) A. T. Hesselink et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Validation of high-risk HPV tests for primary cervical screening

(2009) C.J.L.M. Meijer et al.   JOURNAL OF CLINICAL VIROLOGY

Efficiency of the APTIMA® HPV Assay for detection of HPV RNA and DNA targets

(2009) Damon Getman et al.   JOURNAL OF CLINICAL VIROLOGY

Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

(2009) Janel Dockter et al.   JOURNAL OF CLINICAL VIROLOGY

Analytical characterization of the APTIMA® HPV Assay

(2009) Janel Dockter et al.   JOURNAL OF CLINICAL VIROLOGY

Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears

(2008) A. Szarewski et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER